deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03087773

Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction (EMMY)

Sponsor: Barmherzige Brüder Eisenstadt

Conditions Acute Myocardial Infarction
Interventions Empagliflozin 10 mg Placebo Oral Tablet
Updated 20 times since 2017 Last updated: Aug 19, 2024 Started: May 11, 2017 Primary completion: May 3, 2022 Completion: May 17, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03087773, this PHASE3 trial focuses on Acute Myocardial Infarction and remains completed. Sponsored by Barmherzige Brüder Eisenstadt, it has been updated 20 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Jan 2018 · 7 months · monthly snapshot~Jan 2018 – ~Jun 2018 · 5 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2019 · 7 months · monthly snapshot~Mar 2019 – ~Jan 2020 · 10 months · monthly snapshot~Jan 2020 – ~Mar 2020 · 2 months · monthly snapshot~Mar 2020 – ~Sep 2020 · 6 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2024 · 25 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

20 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Mar 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Mar 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Jun 2022 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

▶ Show 15 earlier versions

  1. May 2022 — Jun 2022 [monthly]

    Active Not Recruiting PHASE3

  2. Dec 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  3. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE3

  4. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  5. Feb 2021 — Oct 2021 [monthly]

    Recruiting PHASE3

  6. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE3

  7. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  8. Mar 2020 — Sep 2020 [monthly]

    Recruiting PHASE3

  9. Jan 2020 — Mar 2020 [monthly]

    Recruiting PHASE3

  10. Mar 2019 — Jan 2020 [monthly]

    Recruiting PHASE3

  11. Aug 2018 — Mar 2019 [monthly]

    Recruiting PHASE3

  12. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE3

  13. Jan 2018 — Jun 2018 [monthly]

    Recruiting PHASE3

  14. Jun 2017 — Jan 2018 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  15. Apr 2017 — Jun 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barmherzige Brüder Eisenstadt
  • Cardinal Schwarzenberg Hospital
  • Hospital Rudolfstiftung
  • Johannes Kepler University of Linz
  • Klinikum Klagenfurt am Wörthersee
  • Landesklinikum Sankt Polten
  • Landeskrankenhaus Feldkirch
  • Landeskrankenhaus II Graz West
  • Medical University of Graz
  • Medical University of Vienna
  • Paracelsus Medical University
  • United Arab Emirates University
Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations